RETA 20 MG

Retatrutide (RETA) is a next-generation triple receptor agonist targeting GLP-1, GIP, and glucagon receptors simultaneously. One of the most researched peptides in the metabolic health space, RETA has shown significant potential for weight management, metabolic regulation, and cardiovascular health in research settings.

• Triple receptor agonist (GLP-1, GIP & Glucagon)
• Advanced metabolic and weight regulation research
• Cardiovascular health potential
• For research/laboratory use only

Research Purposes Only This product is intended for research purposes only. Not for human consumption. Not for veterinary use. Must be handled by qualified professionals in a controlled laboratory environment.

Purity & Quality ≥99% purity. Certificate of Analysis (CoA) available upon request. All products are independently tested for quality and purity.

Storage & Handling Store lyophilised peptide at -20°C. Keep away from direct sunlight and moisture. Reconstitute with Bacteriostatic Water only.